Advertisement

Introduction

  • Antonio Russo
  • Giuseppina Novo
  • Patrizio Lancellotti
  • Fausto J. Pinto
  • Antonio Giordano
Chapter
Part of the Current Clinical Pathology book series (CCPATH)

Abstract

Thanks to more and more effective antineoplastic treatments (target therapies and immunotherapy) and the advances in early diagnosis of tumors, the life expectancy of patients suffering from cancer has significantly increased in the last 5 years [1, 2]. The increase in survival has created a population of patients “long survivors” with chronic cancer disease who are more exposed to develop complications of antineoplastic treatments [3].

References

  1. 1.
    Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefGoogle Scholar
  2. 2.
    De Luca L, Leopardi S, Cavallini C, et al.; EYESHOT Investigators. Contemporary anti-thrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: the EYESHOT Study. Eur Heart J Acute Cardiovasc Care. 2015;4:441–52.CrossRefGoogle Scholar
  3. 3.
    Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–41.CrossRefGoogle Scholar
  4. 4.
    Zamorano JL, Lancellotti P, Munoz DR, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity. Eur Heart J. 2016;37:2768–801.CrossRefGoogle Scholar
  5. 5.
    Koene RJ, Prizment AE, Blaes A, Konety HK. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133:1104–14.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Antonio Russo
    • 1
  • Giuseppina Novo
    • 2
  • Patrizio Lancellotti
    • 3
  • Fausto J. Pinto
    • 4
  • Antonio Giordano
    • 5
  1. 1.Department of Surgical, Oncological and Oral SciencesSection of Medical Oncology, University of PalermoPalermoItaly
  2. 2.Division of CardiologyBiomedical Department of Internal Medicine and Specialities (DIBIMIS), University of PalermoPalermoItaly
  3. 3.University of Liège HospitalLiegeBelgium
  4. 4.Department of CardiologyUniversity Hospital Santa Maria, CHLN University of LisbonLisbonPortugal
  5. 5.Department of Biology, College of Science and Technology, Temple UniversitySbarro Health Research Organization, Inc.PhiladelphiaUSA

Personalised recommendations